About Carrie Lubitz, MD, MPH

Dr. Lubitz is an Associate Professor of Surgery at Harvard Medical School, Section head of the Massachusetts General Hospital Endocrine Surgery Unit, and a senior scientist at the Massachusetts General Hospital Institute for Technology Assessment. She is the Association of Endocrine Surgeons research committee chair and executive council member and the President-elect of the Association of Academic Surgery. Her overarching research mission has been to improve the health and well-being of patients with benign and malignant endocrine-related diseases. She is the principal investigator of an NIH/NCI R-37 (R01-type merit award) award to examine the potential impact of new diagnostic technologies and personalized management strategies in patients with thyroid cancer using mathematical disease simulation modeling and an American Cancer Society Research Scholar Award to develop a patient-reported instrument to assess thyroid-cancer specific quality of life. 

Clinical Interests:

Treats:

Locations

Surgical Oncology Associates
55 Fruit Street
Boston, MA 02114-2696
Phone: 617-643-9473
Fax: 617-724-3895

Mass General/North Shore Center for Outpatient Care
104 Endicott Street
Danvers, MA 01923-3623
Phone: 978-882-6883
Fax: 978-882-6848

Medical Education

  • MD, University of Michigan Medical School
  • Residency, New York Presbyterian Hospital
  • Residency, New York Presbyterian Hospital Weill Cornell
  • Residency, University of Michigan Medical Center
  • Fellowship, Massachusetts General Hospital

American Board Certifications

  • General Surgery, American Board of Surgery
  • General Surgery, American Board of Surgery

Accepted Insurance Plans

Note: This provider may accept more insurance plans than shown; please call the practice to find out if your plan is accepted.


Research

In addition to her clinical practice which focuses on both benign and malignant thyroid, parathyroid, and adrenal disease, Dr. Lubitz has clinical and translational research interests including prediction and decision-analytic modeling to assess the comparative effectiveness and improve the quality of care of patients with endocrine-related disorders. Her current projects involve identifying appropriate and effective diagnostic, surgical, and surveillance strategies for patients with primary hyperaldosteronism and thyroid cancer. She obtained a Master of Public Health through the Harvard School of Public Health and completed her fellowship in the Dana-Farber/Harvard Cancer Center Program in Cancer Outcomes Research Training in 2013. She continues as a senior scientist at the MGH Institute for Technology Assessment.

Publications